If you want to discuss RAC please come over to the RAC forum. More seriously there is no race (sorry for the pun) between RAC and IMU - cancer is far too big a problem to think it will be solved by one technology or approach. IMU's success is RAC's success and vice versa.
To answer your question yes RAC's drug bisantrene showed good efficacy in Ph1 and even better efficacy in Phase 3.
If you want to discuss RAC please come over to the RAC forum....
-
- There are more pages in this discussion • 3,568 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.6¢ | 5.2¢ | $735.1K | 13.70M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 3131146 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 151349 | 3 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |